Global Historical Income Statement

GMRE Stock

USD 7.82 0.05 0.64%

Historical analysis of Global Medical income statement accounts such as Other Operating Expenses of 108.3 M or Operating Income of 39.8 M can show how well Global Medical REIT performed in making a profits. Evaluating Global Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Global Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Global Medical REIT latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Global Medical REIT is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Global Income Statement Analysis

Global Medical REIT Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Global Medical shareholders. The income statement also shows Global investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Global Medical Income Statement Chart

At present, Global Medical's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 39.8 M, whereas Income Tax Expense is forecasted to decline to about 1.1 M.

Ebitda Income Before Tax Income Tax Expense Preferred Stock And Other Adjustments

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Global Medical income statement and is an important metric when analyzing Global Medical REIT profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Global Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Global Medical REIT current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Total Revenue	115.9M	137.3M	140.9M	71.8M
Depreciation And Amortization	79.0M	98.8M	59.0M	40.7M

Total Revenue Depreciation And Amortization

Global Medical income statement Correlations

	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Net Income	Income Tax Expense	Net Income From Continuing Ops	Depreciation And Amortization	Total Revenue	Gross Profit	Cost Of Revenue	Non Recurring	Total Other Income Expense Net	Minority Interest	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other
Interest Expense		0.77	0.98	0.96	0.62	0.99	0.7	0.87	0.38	0.48	0.86	0.81	0.91	0.83	0.82	0.99	-0.73	-0.45	-0.99	0.9	-0.65
Selling General Administrative	0.77		0.81	0.71	0.07	0.72	0.87	0.45	-0.19	0.71	0.43	0.87	0.85	0.87	0.4	0.78	-0.88	-0.42	-0.75	0.76	-0.18
Other Operating Expenses	0.98	0.81		0.94	0.48	0.98	0.76	0.83	0.28	0.56	0.8	0.89	0.94	0.86	0.8	0.97	-0.81	-0.61	-0.98	0.95	-0.61
Operating Income	0.96	0.71	0.94		0.59	0.98	0.75	0.94	0.37	0.57	0.92	0.83	0.93	0.88	0.72	0.97	-0.68	-0.38	-0.96	0.91	-0.54
Ebit	0.62	0.07	0.48	0.59		0.61	-0.07	0.71	0.85	-0.24	0.79	0.08	0.36	0.16	0.8	0.58	-0.07	-0.01	-0.63	0.39	-0.8
Ebitda	0.99	0.72	0.98	0.98	0.61		0.7	0.91	0.41	0.49	0.89	0.83	0.92	0.83	0.83	0.98	-0.72	-0.53	-0.99	0.94	-0.66
Total Operating Expenses	0.7	0.87	0.76	0.75	-0.07	0.7		0.53	-0.29	0.91	0.45	0.92	0.83	0.97	0.22	0.73	-0.81	-0.37	-0.67	0.75	-0.03
Income Before Tax	0.87	0.45	0.83	0.94	0.71	0.91	0.53		0.61	0.35	0.98	0.66	0.8	0.71	0.75	0.88	-0.43	-0.3	-0.89	0.82	-0.6
Net Income	0.38	-0.19	0.28	0.37	0.85	0.41	-0.29	0.61		-0.53	0.68	-0.09	0.14	-0.08	0.69	0.35	0.27	-0.07	-0.41	0.22	-0.73
Income Tax Expense	0.48	0.71	0.56	0.57	-0.24	0.49	0.91	0.35	-0.53		0.24	0.81	0.69	0.85	-0.01	0.53	-0.77	-0.25	-0.46	0.62	0.21
Net Income From Continuing Ops	0.86	0.43	0.8	0.92	0.79	0.89	0.45	0.98	0.68	0.24		0.59	0.75	0.64	0.8	0.86	-0.4	-0.29	-0.88	0.78	-0.67
Depreciation And Amortization	0.81	0.87	0.89	0.83	0.08	0.83	0.92	0.66	-0.09	0.81	0.59		0.94	0.95	0.47	0.83	-0.85	-0.62	-0.81	0.93	-0.21
Total Revenue	0.91	0.85	0.94	0.93	0.36	0.92	0.83	0.8	0.14	0.69	0.75	0.94		0.93	0.62	0.92	-0.8	-0.49	-0.92	0.97	-0.33
Gross Profit	0.83	0.87	0.86	0.88	0.16	0.83	0.97	0.71	-0.08	0.85	0.64	0.95	0.93		0.39	0.85	-0.81	-0.38	-0.81	0.86	-0.17
Cost Of Revenue	0.82	0.4	0.8	0.72	0.8	0.83	0.22	0.75	0.69	-0.01	0.8	0.47	0.62	0.39		0.79	-0.46	-0.57	-0.85	0.72	-0.92
Non Recurring	0.99	0.78	0.97	0.97	0.58	0.98	0.73	0.88	0.35	0.53	0.86	0.83	0.92	0.85	0.79		-0.74	-0.43	-0.99	0.92	-0.62
Total Other Income Expense Net	-0.73	-0.88	-0.81	-0.68	-0.07	-0.72	-0.81	-0.43	0.27	-0.77	-0.4	-0.85	-0.8	-0.81	-0.46	-0.74		0.59	0.73	-0.79	0.28
Minority Interest	-0.45	-0.42	-0.61	-0.38	-0.01	-0.53	-0.37	-0.3	-0.07	-0.25	-0.29	-0.62	-0.49	-0.38	-0.57	-0.43	0.59		0.48	-0.63	0.44
Net Interest Income	-0.99	-0.75	-0.98	-0.96	-0.63	-0.99	-0.67	-0.89	-0.41	-0.46	-0.88	-0.81	-0.92	-0.81	-0.85	-0.99	0.73	0.48		-0.93	0.66
Reconciled Depreciation	0.9	0.76	0.95	0.91	0.39	0.94	0.75	0.82	0.22	0.62	0.78	0.93	0.97	0.86	0.72	0.92	-0.79	-0.63	-0.93		-0.45
Non Operating Income Net Other	-0.65	-0.18	-0.61	-0.54	-0.8	-0.66	-0.03	-0.6	-0.73	0.21	-0.67	-0.21	-0.33	-0.17	-0.92	-0.62	0.28	0.44	0.66	-0.45

Click cells to compare fundamentals

Global Medical Account Relationship Matchups

Global Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	17.5M	18.7M	19.7M	25.2M	30.9M	32.4M
Selling General Administrative	12.8M	30.0M	16.5M	16.5M	16.9M	10.9M
Other Operating Expenses	43.4M	77.2M	78.8M	98.5M	103.1M	108.3M
Operating Income	27.3M	16.5M	37.1M	38.8M	37.9M	39.8M
Ebit	27.3M	(24.5M)	5.0M	(2.3M)	52.6M	55.3M
Ebitda	52.0M	53.0M	84.0M	96.5M	111.6M	117.2M
Total Operating Expenses	37.4M	66.3M	63.3M	73.3M	16.9M	28.7M
Income Before Tax	9.6M	(2.5M)	18.3M	20.0M	21.7M	22.8M
Net Income	(8.2M)	(20.6M)	(2.1M)	(5.2M)	20.6M	21.6M
Income Tax Expense	17.8M	18.1M	20.4M	25.2M	1.1M	1.1M
Net Income From Continuing Ops	9.6M	(2.5M)	18.3M	13.2M	23.0M	24.2M
Net Income Applicable To Common Shares	3.4M	(7.7M)	11.8M	13.3M	15.3M	16.1M
Depreciation And Amortization	24.6M	77.5M	79.0M	98.8M	59.0M	40.7M
Total Revenue	70.7M	93.7M	115.9M	137.3M	140.9M	71.8M
Gross Profit	64.8M	82.9M	100.4M	112.1M	54.7M	55.2M
Cost Of Revenue	6.0M	10.9M	15.5M	25.2M	86.2M	90.5M
Non Recurring	17.7M	19.0M	19.8M	25.6M	29.4M	30.9M
Total Other Income Expense Net	(17.7M)	(30.8M)	(18.8M)	(18.8M)	(16.2M)	(15.4M)
Minority Interest	30.1M	(574K)	(720K)	854K	(1.2M)	(1.2M)
Net Interest Income	(17.5M)	(18.7M)	(19.7M)	(25.2M)	(32.0M)	(30.4M)
Reconciled Depreciation	24.6M	36.3M	46.9M	57.7M	60.0M	39.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:

How To Invest In Global

Details

Is Global Stock a good investment?

Details

What is Global Medical's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.43)

Dividend Share

0.84

Earnings Share

(0.02)

Revenue Per Share

2.082

Quarterly Revenue Growth

(0.04)

The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Global Historical Income Statement

About Global Income Statement Analysis

Global Medical Income Statement Chart

Income Before Tax

Global Medical income statement Correlations

Global Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Global Medical income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 0.99	Interest Expense
Non Recurring	+ 0.99	Interest Expense
Other Operating Expenses	+ 0.98	Interest Expense
Ebitda	+ 0.98	Other Operating Expenses
Ebitda	+ 0.98	Operating Income
Non Recurring	+ 0.98	Ebitda

Net Interest Income	- 0.99	Non Recurring
Net Interest Income	- 0.99	Ebitda
Net Interest Income	- 0.99	Interest Expense
Net Interest Income	- 0.98	Other Operating Expenses
Net Interest Income	- 0.96	Operating Income
Reconciled Depreciation	- 0.93	Net Interest Income